Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Schedule and concentration dependent increase of coagulation times and complement split products in phase I/II trials of an antisense oligonucleotide targeted to protein kinase C-alpha(ISIS 3521/ISI641A). Advani, R., Lum, B. L., Fisher, G. A., Grant, P., Halsey, J., Yuen, A., Holmland, J. T., Kwoh, T. J., Dorr, A., Geary, R., Sikic, B. I. AMER SOC HEMATOLOGY. 1999: 94B
View details for Web of Science ID 000083790700428